Emerging Diseases News

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study.

In 5 years, COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world’s top public health agencies have considered the pandemic phase of COVID-19 to be over for years.

In July of 2022, mpox was declared a Public Health Emergency of International Concern, or PHEIC, by WHO during a surge in infections that led to more than 100,000 cases in 122 countries.

Although infant mortality rates have declined since 1999, there was a recent spike in sudden unexpected infant deaths from 2020 to 2022, according to data published in JAMA Pediatrics.

A 90-day review of U.S. foreign aid spending ordered by President Donald J. Trump has halted global health programs, including the U.S. President’s Emergency Plan for AIDS Relief and the President’s Malaria Initiative.

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a 4-year period, researchers reported.

The severity of multisystem inflammatory syndrome in children decreased as the COVID-19 pandemic went on, and most children recovered to their preinfection health within 6 months, according to two recent studies.

In early December, health officials in the Democratic Republic of the Congo, or DRC, announced that an unknown illness had emerged and had already killed dozens of patients, with hundreds more sick.

The U.S. Department of Agriculture announced that 15 more states have enrolled in a national H5N1 milk testing program, raising the number to 28 states, which represents roughly 65% of the nation’s milk production, the agency said.